Las negociaciones sobre la exención de los ADPIC están en la cuerda floja de cara a la CM12

The document examines the tension between intellectual property rights and public health during the COVID-19 pandemic, specifically focusing on the proposal by India and South Africa for a TRIPS waiver. It details the shift from a broad waiver of multiple TRIPS sections to a narrower 'Quadrilateral' compromise that primarily addresses vaccine exports, while noting the ongoing disputes regarding China's eligibility and the role of the WHO's C-TAP initiative.

• In October 2020, India and South Africa proposed a waiver of the TRIPS Agreement to address the COVID-19 pandemic, specifically requesting an exemption from the enforcement and application of Sections 1, 4, 5, and 7 of Part II, which cover copyrights, industrial designs, patents, and undisclosed information.
• The European Union opposed the initial broad waiver, arguing that intellectual property rights were not a primary obstacle to accessing COVID-19 technologies, and instead proposed a counter-offer focused on trade facilitation, production expansion, and the clarification of compulsory licensing flexibilities.
• Negotiations led by a 'Quadrilateral' group (the WTO, USA, India/South Africa, and the EU) resulted in a significantly diluted version of the original proposal; while the 2020 proposal sought to exempt 40 TRIPS articles, the resulting compromise focused almost exclusively on vaccine exports.
• The United States government insisted that the waiver be limited to vaccines and explicitly exclude China, asserting that China does not require an exemption because it possesses mRNA technology and its own vaccines.
• Parallel to WTO efforts, the WHO established the COVID-19 Technology Access Pool (C-TAP) in May 2020 following a proposal from Costa Rica for a shared-use rights program for pandemic-related technologies.
• In May 2022, US President Joe Biden announced a licensing agreement involving the US National Institutes of Health, the WHO's C-TAP, and the Medicines Patent Pool, covering 11 technologies including the stabilized spike protein used in current vaccines.

APA

Balasubramaniam, T. (n.d.). Las negociaciones sobre la exención de los ADPIC están en la cuerda floja de cara a la CM12. International Institute for Sustainable Development. https://www.iisd.org/es/node/16626

Chicago

Balasubramaniam, Thiru. Las negociaciones sobre la exención de los ADPIC están en la cuerda floja de cara a la CM12. International Institute for Sustainable Development, n.d. https://www.iisd.org/es/node/16626.

Wikipedia

{{cite report |last1=Balasubramaniam |first1=Thiru |title=Las negociaciones sobre la exención de los ADPIC están en la cuerda floja de cara a la CM12 |publisher=International Institute for Sustainable Development |url=https://www.iisd.org/es/node/16626 |access-date=17 August 2026 |via=Climate Insights Directory}}

BibTeX

@techreport{balasubramaniamndlas, author = {Balasubramaniam, Thiru}, title = {{Las negociaciones sobre la exención de los ADPIC están en la cuerda floja de cara a la CM12}}, institution = {International Institute for Sustainable Development}, url = {https://www.iisd.org/es/node/16626}, urldate = {2026-08-17}, note = {Indexed by Climate Insights Directory} }